Daily News Podcast

No meaningful decline in opioid use


 

Over the last decade, opioid use has not significantly declined, despite efforts to educate physicians about the risk of abuse. Also today, the Fitbit Flex is feasible and provides nuanced step-count data in patients with MS, even moderate alcohol use could worsen outcomes in nonalcoholic fatty liver disease, and a new study supports meningococcal B vaccine in children with rare diseases. Listen to the MDedge Daily News for today’s top news.

Recommended Reading

Brain damage, slight benefit seen in epinephrine cardiac arrest
MDedge Neurology
Is fibromyalgia one disorder – or two?
MDedge Neurology
Is fish oil’s heart benefit a fish tale?
MDedge Neurology
Mild cognitive impairment risk slashed by 19% in SPRINT MIND
MDedge Neurology
Blood pressure meds cut cognitive impairment risk
MDedge Neurology
Antibody cleared amyloid plaques, slowed cognitive decline
MDedge Neurology
Free skin cancer screening highlights need
MDedge Neurology
Valsartan cancer risk is low
MDedge Neurology
Finally, new migraine drugs
MDedge Neurology
Changes to doctor payment for in-office drugs
MDedge Neurology